These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 767152)
1. [Main achievements and tasks of pharmacogenetics]. Kudrin AN; Skakun NP; Shendevitskiĭ VI; Sytnik VA Farmatsiia; 1976; 25(1):82-6. PubMed ID: 767152 [No Abstract] [Full Text] [Related]
2. Sounding board. Why are toxic reactions to drugs so often undetected initially? Vesell ES N Engl J Med; 1980 May; 302(18):1027-9. PubMed ID: 6767974 [No Abstract] [Full Text] [Related]
3. [Clinical significance of the induction and repression of the enzymes of drug metabolism]. Bushma MI; Lukienko PI Klin Med (Mosk); 1982 May; 60(5):16-21. PubMed ID: 7109509 [No Abstract] [Full Text] [Related]
4. Pharmacogenetics. Vesell ES N Engl J Med; 1972 Nov; 287(18):904-9. PubMed ID: 4561668 [No Abstract] [Full Text] [Related]
5. Metabolic basis of adverse drug reactions. Park BK J R Coll Physicians Lond; 1986 Jul; 20(3):195-200. PubMed ID: 2874223 [No Abstract] [Full Text] [Related]
6. [Modification of the action of drugs by inhibition of their metabolism]. Park BK; Breckenridge AM; Ohnhaus EE Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953 [No Abstract] [Full Text] [Related]
8. Premedication and drug interaction. Gravenstein JS; Anton AH Clin Anesth; 1969; 3():199-219. PubMed ID: 4941527 [No Abstract] [Full Text] [Related]
9. Ontogeny and drug metabolism in newborns. Dotta A; Chukhlantseva N J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028 [TBL] [Abstract][Full Text] [Related]
10. Altered drug response in hereditary disease. La Du BN Fed Proc; 1965; 24(6):1287-92. PubMed ID: 5853149 [No Abstract] [Full Text] [Related]
11. Cytochrome p450 part 3: drug interactions: essential concepts and considerations. Krau SD Nurs Clin North Am; 2013 Dec; 48(4):697-706. PubMed ID: 24295196 [TBL] [Abstract][Full Text] [Related]
12. [Induction and inhibition of drug-metabolizing enzymes. Significance for pharmacotherapy, toxicity and clinical testing]. Rugstad HE Tidsskr Nor Laegeforen; 1969 Feb; 89(3):172-6. PubMed ID: 5795436 [No Abstract] [Full Text] [Related]
13. [Significance of patient's illness and predisposition on adverse drug reactions]. Helmstaedt D Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1512-8. PubMed ID: 611876 [No Abstract] [Full Text] [Related]
14. [Pharmacogenetics of oxidation reactions of drugs]. Jacqz-Aigrain E Arch Fr Pediatr; 1989 Jan; 46(1):59-65. PubMed ID: 2653266 [TBL] [Abstract][Full Text] [Related]
15. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes. Wada O; Yano Y Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260 [No Abstract] [Full Text] [Related]
16. Immunogenetics of drug-induced skin blistering disorders. Part I: Perspective. Bowman C; Delrieu O Pharmacogenomics; 2009 Apr; 10(4):601-21. PubMed ID: 19374517 [TBL] [Abstract][Full Text] [Related]
17. [Importance of pharmacological interactions in geriatrics]. Ceruso D G Clin Med; 1980 Apr; 61(4):253-74. PubMed ID: 7450348 [No Abstract] [Full Text] [Related]
18. [Pharmacogenetics, its achievements and perspectives (review of the literature)]. Skakun NP Vrach Delo; 1974 Mar; (3):1-4. PubMed ID: 4619733 [No Abstract] [Full Text] [Related]
19. Clinical evaluation of side-effects of drugs. Jacobs HD S Afr Med J; 1973 Aug; 47(30):1365-9. PubMed ID: 4721497 [No Abstract] [Full Text] [Related]
20. Pharmacogenetics. A review of current literature. Watson BM Anaesthesia; 1969 Apr; 24(2):230-48. PubMed ID: 4886844 [No Abstract] [Full Text] [Related] [Next] [New Search]